Dow+1.38 %
25145pts, Nasdaq
+0.67 % a 7689pts , S&P+ 0.85%
2772pts
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi1hPv1ghAg-4bJat7HnkGP8r2W8P_Rx9EsAj8bXe-7-59_tie77mHWt_DEFUKJUVREky3sxLz6YyBHf5ZYZbjpeMR3QSCqp9SNZBKeKrsLJd8Yq3-Dal9Mc7J3sb3YOjNhtK8R1HTWOysw/s200/VBLT.jpg)
$VBLT |
|
|
|
|
|
|
|
Vascular Biogenics Ltd |
|
|
|
|
|
|
|
Industria: Biotecnologia |
|
|
|
|
|
|
Sector:
Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$VBLT subió 35.70% a $2.92 luego de anunciar que su ensayo para el
tratamiento de la enferemedad de
Parkinson |
alcanzo los
objetivos primarios
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhjmWx0MW8aqxgXKo7pLBGyJbfrduEBP4Yqwk9-xdxTqRXecPRyzRIdJwZ3JZP_fazuxtfid7kgB-TZ4qtRWmH-JLZiiDpw7qpPzFSee5ueThfb9z7G1y4dj6eNKYeI80hNLAlh6ISGNguL/s640/VBLT.png)
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiN3_K0PrmDm1UdWe-m_f_o0siDwnqc9vt1MwtgiSzYpgfOpSJQSdR05HYdyh23_aSJ_URA-T3je2kH3BuI6g9xPU3dsay6wY1tPtsAkDfgTTUMP_JgMnMZ0S9QTvUGf5Gpdmi0bEOQg4PB/s200/GEVO.jpg)
$GEVO |
|
|
|
|
|
|
|
Gevo Inc |
|
|
|
|
|
|
|
Industria:
Química Diversificada |
|
|
|
|
|
Sector:
Materiales Básicos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$GEVO Bajó 13.58% a
$3.50 luego de anunciar
resultados por debajo de lo estimados por los analistas
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEggJ8YncZmEyJw8d7X1p4LwTGeU81-pqK7kbBdMH07rre-Fsr4gkZ1USaY9IYZVE0paL9GkYBVwpEHeEqDQ5lHrJbbA6Rz_Zse-a3C9xLSD9tQ667seFwrEqcqlHhyphenhyphentv_kNC_vKnmafrqYM/s640/GEVO.png)
Otros Stocks: |
|
|
|
|
|
|
$AXON
, $IMTE , $SIG , $ENDP , $NDRA , $AMBA , $LTRX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|